ISOVUE-300

LOE Approaching

iopamidol

NDAINJECTIONINJECTABLE
Approved
Dec 1985
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

X-Ray Contrast Activity

Pharmacologic Class:

Radiographic Contrast Agent

Clinical Trials (2)

NCT00782639Phase 4Terminated

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients

Started Mar 2009
23 enrolled
Chronic Renal ImpairmentDiabetes Mellitus
NCT00558792Phase 2Completed

Coronary MDCTA With Iopamidol Injection 370

Started Nov 2007
210 enrolled
Coronary Artery Disease